ABSTRACT We designed this study to examine the relationship ofcryoglobulins to immune complexes in sera ofpatients with rheumatic or infectious diseases. Polyethylene glycol was used to precipitate large proteins from normal serum and then was dialyzed away. The precipitated proteins were soluble in warm phosphate-buffered saline but at 4C they reversibly reprecipitated. As they reprecipitated, they selectively coprecipitated coldsoluble immune complexes. By NaDodSO4/polyacrylamide gel electrophoresis, these normal, nonimmunoglobulin cryoproteins were similar to the nonimmunoglobulin constituents of washed cryoimmunoglobulins from patients with rheumatic or infectious diseases. These findings suggest that cryoprecipitability is a property not of immune complexes themselves but of a group of large normal serum proteins. In inflammatory diseases, the concentrations of some of these proteins, responding as acute-phase reactants, may increase to the point where intermolecular attractive forces become prominent, particularly in the cold. Cold-augmented molecular aggregation between these nonimmunoglobulin proteins and immune complexes could then act to decrease their collective solubility and result in the cryoprecipitation ofotherwise cold-soluble immune complexes. Serum cryoglobulins, described by Lerner and Watson in 1947 (1), are generally thought to derive directly from circulating immune complexes (2, 3), but the mechanism by which they precipitate in the cold is not known. Classical immunoprecipitation of protein antigens involves three-dimensional antigen-antibody lattice structures that generally are larger than those found in most cryoprecipitable sera and whose solubility is relatively independent of temperature (4).
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In previous studies (5) (5 ml) of the serum were combined with equal volumes of 6000 Mr polyethylene glycol (PEG) dissolved at concentrations ranging from 2% to 12% in phosphate-buffered saline (P1/NaCl; 0.01 M P04/0. 15 M NaCl, pH 7.4) and incubated for 1 hr at 40C.
Resulting precipitates were washed three times in Pi/NaCl/ PEG at the same final concentrations used in the initial precipitation step. The precipitates were suspended in Pi/NaCl at a volume 1/10th or 1/5th that of the starting serum and incubated for 1 hr at 37°C. At the end of this step, any material that remained insoluble was sedimented at 10,000 X g for 10 min and discarded. The supernates containing putative CPG were dialyzed against two changes of PJ/NaCl for 48 hr at 4°C to remove any remaining traces of PEG. During this last step a white precipitate formed that dissolved upon rewarming.
Isolation of Cryoprecipitates. Cryoglobulins were isolated from eight patients, two each with systemic lupus erythematosus, rheumatoid arthritis, Lyme disease, and bacterial endocarditis. Blood (usually 50 ml) was obtained by venipuncture and kept at 37°C for 2 hr. The clotted blood was centrifuged at 1000 x g for 10 min at room temperature and the serum was kept at 4°C for 48-96 hr. Any precipitate that formed was sedimented at 1000 X g for 20 min at 40C and washed three times with 10 ml of ice-cold Pi/NaCl. Washed cryoprecipitates were resuspended in 1 ml of Pi/NaCl and incubated at 37°C for 1 hr.
The suspension was centrifuged at 10,000 x g for 10 min, and any remaining insoluble material was discarded. When cryoglobulins were to be examined electrophoretically, washed and redissolved cryoprecipitates were allowed to reprecipitate at 4°C and the analysis was performed on the redissolved material.
Cryoprecipitation of Immune Complexes with CPG. Immune complexes ofknown composition were formed in human serum containing hemaglutinating antitetanus toxoid antibodies at a titer of 1:1200. Tetanus toxoid, previously radiolabeled with "2I by the lactoperoxidase technique (6), was combined with 400-,il aliquots ofthis serum and incubated for 18 hr at 4°C. The mixtures were centrifuged at 15,000 x g; the supernates were divided into two equal portions and combined with an equal volume of either warm Pi/NaCl alone or Pi/NaCl containing dissolved putative CPG at a concentration 10 times that in normal serum. Each aliquot was kept at 4°C for 8 hr before being centrifuged at 8000 x g for 10 min to remove any cryoprecipitates that formed. An aliquot (15 ,ul) of each sample was fractionated on continuous 10-40% sucrose density gradients (4.5 ml) spun in a 50.1 Ti rotor at 25,000 rpm for 14 hr. Gradient tubes were punctured at the bottom, and individual fractions were collected dropwise. The distribution of radiolabeled tetanus toxoid in each gradient was determined in a crystal scintillation spectometer. In some experiments, immune complexes Abbreviations: CPG, cryoprecipitogogue; PEG, polyethylene glycol; PJ/NaCl, phosphate-buffered saline.
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composed of l"I-labeled human albumin-rabbit anti-human albumin were formed in fetal calf serum. These complexes were treated with putative CPG and analyzed in the same way as for complexes based on tetanus toxoid, except that sucrose density gradients were centrifuged at 35,000 rpm for 18 hr.
Other Analytical Methods. Protein preparations were quantified by the Lowry method and compared electrophoretically in NaDodSOJ10% polyacrylamide slab gels. IgG, IgA, and IgM constituents were measured by radial immunodiffusion in Hyland plates. Fibronectin was detected by immunodiffusion in 1% agarose toward specific antiserum kindly supplied by Frederick Grinnell (7) . Putative immune complexes in patients' sera were quantified by means of the 1"I-Clq binding assay described by Zubler et al. (8) . Serum from normal donors was used as a CPG source only if it gave a negative reaction in this assay.
RESULTS
It was postulated that, when the concentrations ofcertain ofthe larger serum proteins were increased, their collective solubility would become temperature sensitive. Therefore, potentially cryoprecipitable proteins were isolated from 5-ml aliquots of normal serum to which various concentrations ofPEG had been added. The proteins precipitated under these conditions were redissolved in 1 ml of Pi/NaCl at 370C and tested for their propensity to precipitate spontaneously at 40C. In general, with increasing concentrations of PEG, increasing amounts of protein were recovered in the 1 ml of warm Pi/NaCl (Table 1) .
Most of the protein recovered with 1% PEG was cryoprecipitable. Relative amounts of cryoprecipitable protein decreased in preparations made with higher concentrations of PEG, especially those above 3%. Upon warming, cryoprecipitated proteins redissolved. When this experiment was repeated with serum heated to 560C for 1 hr, the amounts of reversibly cryoprecipitable proteins obtained were similar to those shown. Thus, complement components must comprise at most only a minor portion of these proteins.
It had been observed (9) that putative immune complexes (i.e., 125I-Clq reactive material) are incorporated into cryoglobulins that form in patients' serum. Thus, it was of interest to determine whether the reversibly cryoprecipitable proteins recovered from normal serum could effect the cryoprecipitation of antigen-antibody complexes-i.e., act as a CPG. In the examples shown in Fig. 1 , soluble tetanus toxoid-antitoxoid complexes or human albumin-rabbit antialbumin complexes were incubated for 8 hr at 40C in the presence or absence ofputative CPG (made with 3% PEG). Those proteins that cryoprecipitated during this incubation were removed and the remaining soluble immune complexes were analyzed on sucrose density gradients in an ultracentrifuge. The radiolabeled antigens sedimented in two peaks: free molecules sedimented near the 7S We found fibronectin both in 3% PEG fractions of normal serum and in cryoglobulins isolated from patients' sera. This protein has several interesting properties that relate it to cryoprecipitation. At 40C, it binds to fibrinogen to form soluble complexes, but this binding is reversible and does not occur in the warm. In certain disease states, fibronectin acts as a nucleus around which circulating cold-soluble fibrinogen-fibrin complexes bind to form cold-insoluble cryofibrinogen. Indeed, the removal of fibronectin from synovial fluid ofpatients with rheumatoid arthritis substantially reduces the formation ofcryoglobulins (10). However, one can deduce that cryoglobulin formation is not related solely to fibronectin. First, this protein by itself is soluble in the cold (11 No visible precipitate formed. The sample was centrifuged and divided into equal parts that were treated with either putative CPG or Pi/NaCl. Aliquots (20 sud) ofeach sample were fractionated on 10-40% sucrose density gradients. A portion ofthe "MI-labeled tetanus toxoid appeared in complexes that sedimented ahead of the 19S marker. These complexes were absent from the sample treated with the putative CPG.
(B) As in A, immune complexes were formed by addition of 1 ng of 125"-labeled human albumin to fetal calf serum containing rabbit anti-human albumin at a dilution of 1:100 and treated with either putative CPG or Pi/NaCl. In the former sample, the total radioactivity in the rapidly sedimenting peak of radioactivity (antibody-bound '251-labeled albumin, the bottom 2 ml of the gradient) was decreased by 60%; the slowly sedimenting peak (unbound '215-labeled albumin, the upper 2.5 ml of the gradient) was decreased by only 17%. plement component (Cl) is necessary for the formation of cryoprecipitate in sera from some patient with systemic lupus erythematosus (12) . It In the present study, the large serum proteins in question were studied at a 5-fold increase in concentration compared to that of their native state within the circulation. Many acutephase reactants respond to inflammation with rapid increases in concentration and could approximate the levels examined in this study. On the other hand, fibronectin levels do not appear to vary much except in circumstances, such as trauma or sepsis, in which enhanced function of the reticuloendothelial system leads to depressed levels (16). It seems reasonable that molecular interactions ofthe type described above might be enhanced during acute-phase responses and thus provide a mechanism for the formation of larger, less-soluble, molecular aggregates. These aggregates might interact with fibronectin or immune complexes to account for the formation of cryoprecipitates in vitro. It is conceivable that these molecular interactions also occur in vivo within cooler regions of the circulation. In some patients, such clinical events as Raynaud's phenomenon and the hyperviscosity syndrome could be based on such a mechanism. A better understanding ofthe nature ofthese interactions might provide insight into new therapeutic options for such problems.
